{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:30:41Z","timestamp":1787315441370,"version":"build-2736575974"},"reference-count":57,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"vor","delay-in-days":558,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006348","name":"Delaney AIDS Research Enterprise","doi-asserted-by":"publisher","award":["A127966"],"award-info":[{"award-number":["A127966"]}],"id":[{"id":"10.13039\/100006348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001117","name":"amfAR, The Foundation for AIDS Research","doi-asserted-by":"publisher","award":["109119"],"award-info":[{"award-number":["109119"]}],"id":[{"id":"10.13039\/100001117","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI122862"],"award-info":[{"award-number":["R01 AI122862"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["K23AI134327"],"award-info":[{"award-number":["K23AI134327"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["T32 AI125222"],"award-info":[{"award-number":["T32 AI125222"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1111\/ajt.16244","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T22:50:09Z","timestamp":1597186209000},"page":"1765-1779","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Everolimus, an mTORC1\/2 inhibitor, in ART-suppressed individuals who received solid organ transplantation: A prospective study"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6684-0622","authenticated-orcid":false,"given":"Timothy J.","family":"Henrich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna","family":"Schreiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise E.","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel L.","family":"Rutishauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia N.","family":"Deitchman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Thanh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica A.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arya","family":"Zarinsefat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Bakkour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Aweeka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teri","family":"Liegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Milush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G.","family":"Deeks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5806-0167","authenticated-orcid":false,"given":"Peter G.","family":"Stock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/ajt.16244_bib1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nri3262","article-title":"Towards an HIV cure: a global scientific strategy","volume":"12","author":"Deeks","year":"2012","journal-title":"Nat Rev Immunol."},{"key":"10.1111\/ajt.16244_bib2","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3389\/fimmu.2012.00312","article-title":"All PI3Kinase signaling is not mTOR: dissecting mTOR-dependent and independent signaling pathways in T cells","volume":"3","author":"Gamper","year":"2012","journal-title":"Front Immunol."},{"key":"10.1111\/ajt.16244_bib3","doi-asserted-by":"crossref","first-page":"34493","DOI":"10.1074\/jbc.274.48.34493","article-title":"Immunopurified mammalian target of rapamycin phosphorylates and activates p70 S6 kinase alpha in vitro","volume":"274","author":"Isotani","year":"1999","journal-title":"J Biol Chem."},{"key":"10.1111\/ajt.16244_bib4","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.drudis.2015.05.006","article-title":"Sirolimus and everolimus in kidney transplantation","volume":"20","author":"Moes","year":"2015","journal-title":"Drug Discov Today."},{"key":"10.1111\/ajt.16244_bib5","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/sj.bmt.1704604","article-title":"Sirolimus for GVHD prophylaxis in allogeneic stem cell transplantation","volume":"34","author":"Cutler","year":"2004","journal-title":"Bone Marrow Transplant."},{"key":"10.1111\/ajt.16244_bib6","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/MOH.0b013e32833e5b2e","article-title":"Sirolimus immunosuppression for graft-versus-host disease prophylaxis and therapy: an update","volume":"17","author":"Cutler","year":"2010","journal-title":"Curr Opin Hematol."},{"key":"10.1111\/ajt.16244_bib7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/TP.0000000000001438","article-title":"Use of everolimus in liver transplantation: recommendations from a working group","volume":"101","author":"De Simone","year":"2017","journal-title":"Transplantation."},{"key":"10.1111\/ajt.16244_bib8","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/TP.0b013e3181c7dcc0","article-title":"First report on a series of HIV patients undergoing rapamycin monotherapy after liver transplantation","volume":"89","author":"Di Benedetto","year":"2010","journal-title":"Transplantation."},{"key":"10.1111\/ajt.16244_bib9","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1365-2125.2010.03735.x","article-title":"Potential use of rapamycin in HIV infection","volume":"70","author":"Donia","year":"2010","journal-title":"Br J Clin Pharmacol."},{"key":"10.1111\/ajt.16244_bib10","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jhep.2005.08.005","article-title":"Sustained, spontaneous disappearance of serum HCV-RNA under immunosuppression after liver transplantation for HCV cirrhosis","volume":"43","author":"Samonakis","year":"2005","journal-title":"J Hepatol."},{"key":"10.1111\/ajt.16244_bib11","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/ajt.12699","article-title":"Reduction of HIV persistence following transplantation in HIV-infected kidney transplant recipients","volume":"14","author":"Stock","year":"2014","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.16244_bib12","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1002\/eji.200424892","article-title":"HIV infection of primary human T cells is determined by tunable thresholds of T cell activation","volume":"34","author":"Oswald-Richter","year":"2004","journal-title":"Eur J Immunol."},{"key":"10.1111\/ajt.16244_bib13","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1128\/AAC.46.11.3447-3455.2002","article-title":"The immunosuppressant rapamycin represses human immunodeficiency virus type 1 replication","volume":"46","author":"Roy","year":"2002","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1111\/ajt.16244_bib14","doi-asserted-by":"crossref","first-page":"20476","DOI":"10.1073\/pnas.0810843106","article-title":"Reduction of CCR5 with low-dose rapamycin enhances the antiviral activity of vicriviroc against both sensitive and drug-resistant HIV-1","volume":"105","author":"Heredia","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1111\/ajt.16244_bib15","doi-asserted-by":"crossref","first-page":"9412","DOI":"10.1073\/pnas.1511144112","article-title":"Targeting of mTOR catalytic site inhibits multiple steps of the HIV-1 lifecycle and suppresses HIV-1 viremia in humanized mice","volume":"112","author":"Heredia","year":"2015","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1111\/ajt.16244_bib16","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1593\/neo.13432","article-title":"Improved clearance during treatment of HPV-positive head and neck cancer through mTOR inhibition","volume":"15","author":"Coppock","year":"2013","journal-title":"Neoplasia."},{"key":"10.1111\/ajt.16244_bib17","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1158\/1078-0432.CCR-11-2824","article-title":"mTOR as a molecular target in HPV-associated oral and cervical squamous carcinomas","volume":"18","author":"Molinolo","year":"2012","journal-title":"Clin Cancer Res."},{"key":"10.1111\/ajt.16244_bib18","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1097\/QAD.0b013e3282f02a4f","article-title":"Rapamycin reduces CCR5 mRNA levels in macaques: potential applications in HIV-1 prevention and treatment","volume":"21","author":"Gilliam","year":"2007","journal-title":"AIDS."},{"key":"10.1111\/ajt.16244_bib19","doi-asserted-by":"crossref","first-page":"10411","DOI":"10.1073\/pnas.1834278100","article-title":"Rapamycin causes down-regulation of CCR5 and accumulation of anti-HIV beta-chemokines: an approach to suppress R5 strains of HIV-1","volume":"100","author":"Heredia","year":"2003","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1111\/ajt.16244_bib20","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/ni.2741","article-title":"The kinase mTOR modulates the antibody response to provide cross-protective immunity to lethal infection with influenza virus","volume":"14","author":"Keating","year":"2013","journal-title":"Nat Immunol."},{"key":"10.1111\/ajt.16244_bib21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1586\/1744666X.2014.872562","article-title":"The pros and the cons of mTOR inhibitors in kidney transplantation","volume":"10","author":"Ponticelli","year":"2014","journal-title":"Expert Rev Clin Immunol."},{"key":"10.1111\/ajt.16244_bib22","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1182\/blood-2004-10-3932","article-title":"Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells","volume":"105","author":"Battaglia","year":"2005","journal-title":"Blood."},{"key":"10.1111\/ajt.16244_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-1-4615-1809-9_5","article-title":"Mechanism of action of rapamycin: new insights into the regulation of G1-phase progression in eukaryotic cells","volume":"1","author":"Wiederrecht","year":"1995","journal-title":"Prog Cell Cycle Res."},{"key":"10.1111\/ajt.16244_bib24","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/01.TP.0000164142.98167.4B","article-title":"Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin on the induction of FOXP3 in human T cells","volume":"80","author":"Baan","year":"2005","journal-title":"Transplantation."},{"key":"10.1111\/ajt.16244_bib25","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1182\/blood-2004-10-3927","article-title":"Cyclosporin A and tacrolimus, but not rapamycin, inhibit MHC-restricted antigen presentation pathways in dendritic cells","volume":"105","author":"Lee","year":"2005","journal-title":"Blood."},{"key":"10.1111\/ajt.16244_bib26","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.chom.2016.11.001","article-title":"The mTOR complex controls HIV latency","volume":"20","author":"Besnard","year":"2016","journal-title":"Cell Host Microbe."},{"key":"10.1111\/ajt.16244_bib27","first-page":"435","article-title":"Survival in HIV-positive transplant recipients compared with transplant candidates and with HIV-negative controls","volume":"30","author":"Roland","year":"2016","journal-title":"AIDS."},{"key":"10.1111\/ajt.16244_bib28","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/00007691-200410000-00007","article-title":"Everolimus therapeutic concentration range defined from a prospective trial with reduced-exposure cyclosporine in de novo kidney transplantation","volume":"26","author":"Kovarik","year":"2004","journal-title":"Ther Drug Monit."},{"key":"10.1111\/ajt.16244_bib29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ebiom.2017.05.006","article-title":"High-throughput characterization of HIV-1 reservoir reactivation using a single-cell-in-droplet PCR assay","volume":"20","author":"Yucha","year":"2017","journal-title":"EBioMedicine."},{"key":"10.1111\/ajt.16244_bib30","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jviromet.2012.08.019","article-title":"Low-level detection and quantitation of cellular HIV-1 DNA and 2-LTR circles using droplet digital PCR","volume":"186","author":"Henrich","year":"2012","journal-title":"J Virol Methods."},{"key":"10.1111\/ajt.16244_bib31","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/nprot.2008.108","article-title":"A universal real-time PCR assay for the quantification of group-M HIV-1 proviral load","volume":"3","author":"Malnati","year":"2008","journal-title":"Nat Protoc."},{"key":"10.1111\/ajt.16244_bib32","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jcv.2016.02.002","article-title":"Aptima HIV-1 Quant Dx\u2013a fully automated assay for both diagnosis and quantification of HIV-1","volume":"77","author":"Nair","year":"2016","journal-title":"J Clin Virol."},{"key":"10.1111\/ajt.16244_bib33","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1128\/JCM.00425-17","article-title":"Evaluation of the Aptima HIV-1 Quant Dx assay for HIV-1 RNA quantitation in different biological specimen types","volume":"55","author":"Yek","year":"2017","journal-title":"J Clin Microbiol."},{"key":"10.1111\/ajt.16244_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033328","article-title":"Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies","volume":"7","author":"Duong","year":"2012","journal-title":"PLoS One."},{"key":"10.1111\/ajt.16244_bib35","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1128\/JCM.01454-12","article-title":"Lower-sensitivity and avidity modifications of the vitros anti-HIV 1+2 assay for detection of recent HIV infections and incidence estimation","volume":"50","author":"Keating","year":"2012","journal-title":"J Clin Microbiol."},{"issue":"16","key":"10.1111\/ajt.16244_bib36","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1097\/QAD.0000000000000429","article-title":"Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository","volume":"28","author":"Kassanjee","year":"2014","journal-title":"AIDS."},{"key":"10.1111\/ajt.16244_bib37","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/1471-2105-15-182","article-title":"Skewer: a fast and accurate adapter trimmer for next-generation sequencing paired-end reads","volume":"15","author":"Jiang","year":"2014","journal-title":"BMC Bioinformatics."},{"key":"10.1111\/ajt.16244_bib38","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.3317","article-title":"HISAT: a fast spliced aligner with low memory requirements","volume":"12","author":"Kim","year":"2015","journal-title":"Nat Methods."},{"key":"10.1111\/ajt.16244_bib39","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The sequence alignment\/map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics."},{"key":"10.1111\/ajt.16244_bib40","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics."},{"key":"10.1111\/ajt.16244_bib41","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics."},{"key":"10.1111\/ajt.16244_bib42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"Hanzelmann","year":"2013","journal-title":"BMC Bioinformatics."},{"key":"10.1111\/ajt.16244_bib43","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1111\/ajt.16244_bib44","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1038\/emboj.2008.120","article-title":"The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C","volume":"27","author":"Facchinetti","year":"2008","journal-title":"EMBO J."},{"key":"10.1111\/ajt.16244_bib45","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/emboj.2008.119","article-title":"Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling","volume":"27","author":"Ikenoue","year":"2008","journal-title":"EMBO J."},{"key":"10.1111\/ajt.16244_bib46","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.4049\/jimmunol.181.4.2265","article-title":"Thymic emigration: when and how T cells leave home","volume":"181","author":"Weinreich","year":"2008","journal-title":"J Immunol."},{"key":"10.1111\/ajt.16244_bib47","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.4049\/jimmunol.1402256","article-title":"Cutting edge: CD69 interference with sphingosine-1-phosphate receptor function regulates peripheral T cell retention","volume":"194","author":"Mackay","year":"2015","journal-title":"J Immunol."},{"key":"10.1111\/ajt.16244_bib48","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/eji.201646837","article-title":"CD69: from activation marker to metabolic gatekeeper","volume":"47","author":"Cibrian","year":"2017","journal-title":"Eur J Immunol."},{"key":"10.1111\/ajt.16244_bib49","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jaut.2014.05.007","article-title":"Maintenance of immune tolerance by Foxp3+ regulatory T cells requires CD69 expression","volume":"55","author":"Cort\u00e9s","year":"2014","journal-title":"J Autoimmun."},{"key":"10.1111\/ajt.16244_bib50","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","article-title":"Mycophenolate mofetil and its mechanisms of action","volume":"47","author":"Allison","year":"2000","journal-title":"Immunopharmacology."},{"key":"10.1111\/ajt.16244_bib51","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1038\/s41598-017-04160-3","article-title":"Anti-proliferative therapy for HIV cure: a compound interest approach","volume":"7","author":"Reeves","year":"2017","journal-title":"Sci Rep."},{"key":"10.1111\/ajt.16244_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006285","article-title":"Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation","volume":"13","author":"Gandhi","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1111\/ajt.16244_bib53","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/cid\/ciu585","article-title":"HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy","volume":"59","author":"Besson","year":"2014","journal-title":"Clin Infect Dis."},{"key":"10.1111\/ajt.16244_bib54","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/annonc\/mdx696","article-title":"Drastic decrease of the HIV reservoir in a patient treated with nivolumab for lung cancer","volume":"29","author":"Guihot","year":"2018","journal-title":"Ann Oncol."},{"key":"10.1111\/ajt.16244_bib55","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1097\/QAD.0000000000001429","article-title":"Transient HIV-specific T cells increase and inflammation in an HIV-infected patient treated with nivolumab","volume":"31","author":"Le Garff","year":"2017","journal-title":"AIDS."},{"issue":"10","key":"10.1111\/ajt.16244_bib56","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1093\/annonc\/mdy259","article-title":"Inconsistent HIV reservoir dynamics and immune responses following anti-PD-1 therapy in cancer patients with HIV infection","volume":"29","author":"Scully","year":"2018","journal-title":"Ann Oncol."},{"key":"10.1111\/ajt.16244_bib57","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08155","article-title":"mTOR regulates memory CD8 T-cell differentiation","volume":"460","author":"Araki","year":"2009","journal-title":"Nature."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.16244","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.16244","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajt.16244","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522085409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522085409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.16244","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:31:57Z","timestamp":1761629517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522085409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1600613522085409"],"URL":"https:\/\/doi.org\/10.1111\/ajt.16244","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Everolimus, an mTORC1\/2 inhibitor, in ART-suppressed individuals who received solid organ transplantation: A prospective study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.16244","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}